NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

TWST

Twist Bioscience Corp

May 15 • 04:00PM ET

30.10

Dollar change +0.58
Percentage change 1.96	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN PACB CRSP EDIT NTLA BEAM SGMO AMGN REGN BIIB

| Held by: ARKK VTI ARKG VB IWM VXF XBI VBK IWO VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.26	Insider Own	6.83%	Shs Outstand	59.86M	Perf Week	-7.70%
Market Cap	1.80B	Forward P/E	-	EPS next Y	-1.36	Insider Trans	-2.15%	Shs Float	55.82M	Perf Month	-23.80%
Income	-191.15M	PEG	-	EPS next Q	-0.52	Inst Own	107.02%	Short Float	17.85%	Perf Quarter	-35.78%
Sales	347.68M	P/S	5.19	EPS this Y	40.93%	Inst Trans	1.38%	Short Ratio	8.13	Perf Half Y	-36.34%
Book/sh	7.35	P/B	4.09	EPS next Y	35.82%	ROA	-29.44%	Short Interest	9.96M	Perf Year	-36.54%
Cash/sh	4.29	P/C	7.01	EPS next 5Y	38.71%	ROE	-38.22%	52W Range	29.44 - 60.90	Perf YTD	-35.23%
Dividend Est.	-	P/FCF	-	EPS past 5Y	1.70%	ROI	-37.84%	52W High	-50.57%	Beta	2.40
Dividend TTM	-	Quick Ratio	4.24	Sales past 5Y	42.89%	Gross Margin	46.70%	52W Low	2.22%	ATR (14)	2.82
Dividend Ex-Date	-	Current Ratio	4.51	EPS Y/Y TTM	2.75%	Oper. Margin	-44.94%	RSI (14)	35.24	Volatility	7.56% 7.05%
Employees	923	Debt/Eq	0.18	Sales Y/Y TTM	25.30%	Profit Margin	-54.98%	Recom	1.77	Target Price	48.55
Option/Short	Yes / Yes	LT Debt/Eq	0.15	EPS Q/Q	16.26%	Payout	-	Rel Volume	0.92	Prev Close	29.52
Sales Surprise	0.88%	EPS Surprise	-20.39%	Sales Q/Q	23.23%	Earnings	May 05 BMO	Avg Volume	1.23M	Price	30.10
SMA20	-15.31%	SMA50	-20.87%	SMA200	-31.08%	Trades		Volume	1,125,699	Change	1.96%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Jun-04-24	Initiated	Guggenheim	Buy	$53
Jan-17-24	Upgrade	Goldman	Neutral → Buy	$25 → $45
Sep-27-23	Initiated	Berenberg	Buy	$27
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$33
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform	$28 → $36
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral	$110
Apr-12-21	Initiated	Piper Sandler	Overweight	$150
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight	$100
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform	$90
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral	$27

Show Previous Ratings

May-15-25 08:00AM	Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference (Business Wire)
May-13-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-08-25 11:43PM	Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) -5.49%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 03:02AM	Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -8.85%
01:18AM	Loading…
01:18AM	Q2 2025 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
May-05-25 11:41AM	Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript (Seeking Alpha) -8.44%
08:25AM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results (Business Wire)
07:10AM	Twist Bioscience Spins Out DNA Data Storage as Independent Company (Business Wire)
May-02-25 09:23AM	What To Expect From Twist Bioscience Corp (TWST) Q2 2025 Earnings (GuruFocus.com)
May-01-25 02:06PM	Twist Bioscience: Experiencing Solid Growth But Significantly Overvalued (Seeking Alpha)
12:05PM	Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers (Seeking Alpha)
Apr-24-25 08:00AM	Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System (Business Wire) +6.78%
08:00AM	Loading…
Apr-14-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025 (Business Wire)
Mar-31-25 09:03AM	The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics (Zacks)
08:00AM	Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics (Business Wire)
Mar-28-25 09:39AM	Promising Genomics & Synthetic Biology Stocks to Consider in 2025 (Zacks)
Mar-20-25 04:58PM	Twist Bioscience (TWST): The Worst High-Risk High-Reward Growth Stock to Buy (InsiderMonkey)
Mar-12-25 12:12PM	Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last? (Zacks)
Mar-11-25 07:30AM	Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost (Business Wire) +6.59%
Mar-01-25 02:38PM	Is Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now? (Insider Monkey)
Feb-25-25 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
Feb-19-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Feb-06-25 04:58PM	Twist Bioscience Corporation (TWST): Among Cathie Woods Top Stock Picks for 2025 (Insider Monkey)
12:00PM	Twist Bioscience (TWST) Upgraded to Buy: Here's What You Should Know (Zacks)
Feb-04-25 02:01AM	Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
12:47AM	Q1 2025 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-03-25 08:25AM	Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Loading…
07:25AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results (Business Wire)
Jan-31-25 07:05AM	Twist Bioscience Corp (TWST) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
Jan-22-25 08:00AM	Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025 (Business Wire)
Dec-27-24 12:00PM	All You Need to Know About Twist Bioscience (TWST) Rating Upgrade to Buy (Zacks)
Dec-23-24 08:48AM	Twist Bioscience (TWST) Surges 9.9%: Is This an Indication of Further Gains? (Zacks)
Dec-19-24 08:00AM	Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-16-24 09:55AM	Twist Bioscience (TWST) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Dec-11-24 11:59AM	Why Twist Bioscience (TWST) Is the Worst ARK Stock to Buy According to Short Sellers (Insider Monkey) -5.24%
Nov-27-24 07:30AM	Twist Bioscience named a Best Idea for 2025 at TD Cowen (TipRanks)
Nov-20-24 09:15AM	AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care (PR Newswire)
Nov-19-24 09:15PM	Twist Bioscience price target lowered to $52 from $55 at Barclays (TipRanks)
06:49PM	Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
02:33AM	Q4 2024 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
02:02AM	Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Nov-18-24 12:17PM	Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps (Benzinga) +12.31%
08:25AM	Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:33AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results (Business Wire)
Nov-15-24 10:44PM	Twist Bioscience Corp (TWST) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com) -5.31%
Nov-14-24 08:00AM	Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference (Business Wire) -8.31%
Nov-07-24 04:05PM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Oct-31-24 08:00AM	Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI (GlobeNewswire) -6.53%
Oct-30-24 08:00AM	Twist Bioscience Launches FlexPrep Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics (Business Wire)
Oct-24-24 08:00AM	Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024 (Business Wire)
Oct-22-24 08:00AM	Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash (Business Wire)
Oct-15-24 08:00AM	Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer (Business Wire)
Sep-12-24 08:00AM	Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance (Business Wire)
Sep-09-24 08:00AM	Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels (Business Wire)
Sep-08-24 03:55PM	Twist Bioscience Corporation (TWST): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)
Aug-27-24 08:00AM	Twist Bioscience to Present at Baird Global Healthcare Conference 2024 (Business Wire)
Aug-14-24 09:45AM	How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates (GlobeNewswire)
Aug-08-24 08:00AM	Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb (Business Wire)
Aug-07-24 06:47AM	3 Healthcare AI Stocks Positioned for Potential Breakthroughs (InvestorPlace)
Aug-06-24 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Aug-05-24 11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace) +5.49%
08:00AM	Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis (Business Wire)
Aug-02-24 08:40AM	Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -19.00%
07:37AM	Twist Bioscience: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results (Business Wire)
Jul-30-24 02:17AM	Is Twist Bioscience Corporation (TWST) in the Pole Position? (Insider Monkey)
Jul-26-24 10:00AM	Twist Bioscience (TWST) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Jul-18-24 08:00AM	Twist Bioscience Announces Clinical Progression of Pure Biologics Antibody Candidate Discovered Using Twists Antibody Libraries (Business Wire)
Jul-11-24 08:00AM	Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024 (Business Wire)
Jul-10-24 08:00AM	Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies (Business Wire)
Jul-09-24 08:00AM	Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A (Business Wire)
Jul-01-24 07:08PM	Is Twist Bioscience Corporation (TWST) a Good Stock to Buy and Hold for 5 Years? (Insider Monkey)
02:31PM	10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood (Insider Monkey)
Jun-06-24 08:00AM	Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor (Business Wire)
Jun-04-24 08:00AM	Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety (Business Wire) +6.75%
May-24-24 04:58PM	IBD 50 Stock Reverses Badly As Weight-Loss Boost Fades Fast; Cathie Wood Stock Falls Hard (Investor's Business Daily)
May-23-24 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
May-22-24 12:00PM	What Makes Twist Bioscience (TWST) a Strong Momentum Stock: Buy Now? (Zacks)
May-13-24 08:00AM	Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications (Business Wire) +11.94%
May-10-24 06:00AM	Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life (InvestorPlace)
May-08-24 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-03-24 03:55PM	Sector Update: Health Care Stocks Mixed Late Afternoon (MT Newswires) +28.74%
01:58PM	Sector Update: Health Care Stocks Mixed in Afternoon Trading (MT Newswires)
01:22PM	Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised (MT Newswires)
10:02AM	Twist Bioscience Corporation (NASDAQ:TWST) Q2 2024 Earnings Call Transcript (Insider Monkey)
06:47AM	Q2 2024 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
04:05AM	Twist Bioscience Corp (TWST) Q2 2024 Earnings Call Transcript Highlights: Key Financial ... (GuruFocus.com)
May-02-24 09:00PM	TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
05:35PM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:33PM	Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results (Business Wire)
Apr-30-24 03:20PM	3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition (InvestorPlace)
Apr-25-24 11:31AM	5 Fastest Growing Health Tech Companies in the World (Insider Monkey)
Apr-18-24 08:00AM	Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024 (Business Wire)

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Finn Patrick John	President and COO	May 08 '25	Sale	32.31	20,000	646,260	242,660	May 12 04:05 PM
Cho Dennis	See Remarks	May 07 '25	Sale	32.72	5,000	163,590	105,849	May 09 04:05 PM
Finn Patrick John	Officer	May 08 '25	Proposed Sale	32.31	20,000	646,257		May 08 12:21 PM
Cho Dennis	Officer	May 07 '25	Proposed Sale	32.72	5,000	163,590		May 07 04:35 PM
Cho Dennis	See Remarks	May 05 '25	Sale	37.65	689	25,942	110,849	May 07 04:05 PM
Finn Patrick John	President and COO	May 05 '25	Sale	37.65	2,800	105,423	262,660	May 07 04:05 PM
Green Paula	SVP of Human Resources	May 05 '25	Sale	37.65	1,101	41,454	129,380	May 07 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	May 05 '25	Sale	37.65	162	6,099	51,272	May 07 04:05 PM
Leproust Emily M.	Chief Executive Officer	May 05 '25	Sale	37.65	5,042	189,836	655,432	May 07 04:05 PM
Finn Patrick John	Officer	May 05 '25	Proposed Sale	37.65	2,800	105,423		May 05 04:29 PM
WERNER ROBERT F.	Officer	May 05 '25	Proposed Sale	37.65	162	6,099		May 05 03:31 PM
Green Paula	Officer	May 05 '25	Proposed Sale	37.65	1,101	41,454		May 05 03:30 PM
Cho Dennis	Officer	May 05 '25	Proposed Sale	37.65	689	25,942		May 05 03:22 PM
Leproust Emily M.	Officer	May 05 '25	Proposed Sale	37.65	5,042	189,836		May 05 03:18 PM
Finn Patrick John	President and COO	Apr 23 '25	Sale	39.99	2,058	82,310	265,460	Apr 25 04:05 PM
Finn Patrick John	Officer	Apr 23 '25	Proposed Sale	40.00	2,058	82,311		Apr 23 03:17 PM
Laponis Adam	Officer	Apr 09 '25	Proposed Sale	34.97	2,542	88,887		Apr 09 03:17 PM
Cho Dennis	See Remarks	Apr 02 '25	Sale	38.73	124	4,803	111,538	Apr 04 04:05 PM
Finn Patrick John	President and COO	Apr 02 '25	Sale	38.73	206	7,979	267,518	Apr 04 04:05 PM
Green Paula	SVP of Human Resources	Apr 02 '25	Sale	38.73	140	5,423	130,481	Apr 04 04:05 PM
Leproust Emily M.	Chief Executive Officer	Apr 02 '25	Sale	38.73	492	19,057	660,474	Apr 04 04:05 PM
Leproust Emily M.	Officer	Apr 02 '25	Proposed Sale	38.73	492	19,057		Apr 02 03:44 PM
Green Paula	Officer	Apr 02 '25	Proposed Sale	38.73	140	5,423		Apr 02 03:29 PM
Cho Dennis	Officer	Apr 02 '25	Proposed Sale	38.73	124	4,803		Apr 02 03:15 PM
Finn Patrick John	Officer	Apr 02 '25	Proposed Sale	38.73	206	7,979		Apr 02 03:15 PM
Cho Dennis	See Remarks	Mar 20 '25	Sale	41.68	230	9,585	111,662	Mar 24 04:09 PM
Green Paula	SVP of Human Resources	Mar 20 '25	Sale	41.68	291	12,128	130,621	Mar 24 04:08 PM
Leproust Emily M.	Chief Executive Officer	Mar 20 '25	Sale	41.68	1,726	71,933	660,966	Mar 24 04:08 PM
Leproust Emily M.	Officer	Mar 20 '25	Proposed Sale	41.68	1,726	71,933		Mar 20 03:59 PM
Cho Dennis	Officer	Mar 20 '25	Proposed Sale	41.68	230	9,585		Mar 20 03:21 PM
Green Paula	Officer	Mar 20 '25	Proposed Sale	41.68	291	12,128		Mar 20 03:16 PM
Cho Dennis	See Remarks	Mar 14 '25	Sale	40.05	92	3,684	111,892	Mar 18 04:05 PM
Cho Dennis	Officer	Mar 14 '25	Proposed Sale	40.05	92	3,684		Mar 14 03:17 PM
Green Paula	SVP of Human Resources	Mar 06 '25	Sale	40.91	918	37,558	130,912	Mar 10 04:05 PM
Cho Dennis	See Remarks	Mar 06 '25	Sale	40.91	277	11,333	111,984	Mar 10 04:05 PM
Leproust Emily M.	Chief Executive Officer	Mar 06 '25	Sale	40.91	2,402	98,273	662,692	Mar 10 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Mar 06 '25	Sale	40.91	241	9,860	51,434	Mar 10 04:05 PM
Leproust Emily M.	Officer	Mar 06 '25	Proposed Sale	40.91	2,402	98,273		Mar 06 03:24 PM
Green Paula	Officer	Mar 06 '25	Proposed Sale	40.91	918	37,558		Mar 06 03:21 PM
Cho Dennis	Officer	Mar 06 '25	Proposed Sale	40.91	277	11,333		Mar 06 03:15 PM
WERNER ROBERT F.	Officer	Mar 06 '25	Proposed Sale	40.91	241	9,860		Mar 06 03:14 PM
WERNER ROBERT F.	Chief Accounting Officer	Feb 24 '25	Sale	41.71	916	38,209	51,675	Feb 25 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Feb 21 '25	Sale	44.18	267	11,795	52,591	Feb 25 04:05 PM
Cho Dennis	See Remarks	Feb 21 '25	Sale	44.18	526	23,237	112,261	Feb 25 04:05 PM
Finn Patrick John	President and COO	Feb 21 '25	Sale	44.18	1,839	81,242	267,724	Feb 25 04:05 PM
Green Paula	SVP of Human Resources	Feb 21 '25	Sale	44.18	618	27,301	131,830	Feb 25 04:05 PM
Laponis Adam	Chief Financial Officer	Feb 21 '25	Sale	44.18	918	40,554	109,496	Feb 25 04:05 PM
Leproust Emily M.	Chief Executive Officer	Feb 21 '25	Sale	44.18	2,790	123,254	665,094	Feb 25 04:05 PM
WERNER ROBERT F.	Officer	Feb 24 '25	Proposed Sale	41.71	916	38,209		Feb 24 03:20 PM
Leproust Emily M.	Officer	Feb 21 '25	Proposed Sale	44.18	2,790	123,253		Feb 21 03:18 PM
Cho Dennis	Officer	Feb 21 '25	Proposed Sale	44.18	526	23,237		Feb 21 03:13 PM
WERNER ROBERT F.	Officer	Feb 21 '25	Proposed Sale	44.18	267	11,795		Feb 21 03:13 PM
Green Paula	Officer	Feb 21 '25	Proposed Sale	44.18	618	27,301		Feb 21 03:13 PM
Finn Patrick John	Officer	Feb 21 '25	Proposed Sale	44.18	1,839	81,241		Feb 21 03:10 PM
Laponis Adam	Officer	Feb 21 '25	Proposed Sale	44.18	918	40,554		Feb 21 03:09 PM
CHESS ROBERT	Director	Feb 07 '25	Sale	53.13	2,940	156,217	18,173	Feb 11 04:05 PM
Chess Robert Bruce	Director	Feb 07 '25	Proposed Sale	53.13	2,940	156,215		Feb 07 03:16 PM
WERNER ROBERT F.	Chief Accounting Officer	Feb 03 '25	Sale	49.35	185	9,130	52,858	Feb 05 04:15 PM
Leproust Emily M.	Chief Executive Officer	Feb 03 '25	Sale	49.35	5,200	256,630	667,318	Feb 05 04:15 PM
Green Paula	SVP of Human Resources	Feb 03 '25	Sale	49.35	1,259	62,134	132,014	Feb 05 04:15 PM
Finn Patrick John	President and COO	Feb 03 '25	Sale	49.35	2,845	140,406	269,199	Feb 05 04:15 PM
Cho Dennis	See Remarks	Feb 03 '25	Sale	49.35	806	39,778	112,221	Feb 05 04:15 PM
WERNER ROBERT F.	Officer	Feb 03 '25	Proposed Sale	49.35	185	9,130		Feb 03 03:24 PM
Leproust Emily M.	Officer	Feb 03 '25	Proposed Sale	49.35	5,200	256,630		Feb 03 03:23 PM
Green Paula	Officer	Feb 03 '25	Proposed Sale	49.35	1,259	62,134		Feb 03 03:18 PM
Finn Patrick John	Officer	Feb 03 '25	Proposed Sale	49.35	2,845	140,406		Feb 03 03:18 PM
Cho Dennis	Officer	Feb 03 '25	Proposed Sale	49.35	806	39,778		Feb 03 03:08 PM
Finn Patrick John	President and COO	Jan 23 '25	Sale	50.17	2,422	121,501	272,044	Jan 27 04:05 PM
Finn Patrick John	Officer	Jan 23 '25	Proposed Sale	50.17	2,422	121,501		Jan 23 03:18 PM
Laponis Adam	Chief Financial Officer	Jan 10 '25	Sale	43.26	5,886	254,646	110,096	Jan 14 04:05 PM
CHESS ROBERT	Director	Jan 07 '25	Sale	50.00	5,000	250,000	16,641	Jan 10 04:05 PM
Laponis Adam	Officer	Jan 10 '25	Proposed Sale	43.26	5,886	254,645		Jan 10 03:15 PM
Cho Dennis	See Remarks	Jan 03 '25	Sale	45.59	144	6,565	113,027	Jan 07 05:47 PM
Finn Patrick John	President and COO	Jan 03 '25	Sale	45.59	229	10,440	274,466	Jan 07 05:47 PM
Green Paula	SVP of Human Resources	Jan 03 '25	Sale	45.59	160	7,295	133,273	Jan 07 05:46 PM
Leproust Emily M.	Chief Executive Officer	Jan 03 '25	Sale	45.59	546	24,893	672,518	Jan 07 05:45 PM
Chess Robert Bruce	Director	Jan 07 '25	Proposed Sale	50.00	5,000	250,000		Jan 07 12:09 PM
Leproust Emily M.	Officer	Jan 03 '25	Proposed Sale	45.59	546	24,893		Jan 03 04:17 PM
Cho Dennis	Officer	Jan 03 '25	Proposed Sale	45.59	144	6,565		Jan 03 03:55 PM
Green Paula	Officer	Jan 03 '25	Proposed Sale	45.59	160	7,295		Jan 03 03:41 PM
Finn Patrick John	Officer	Jan 03 '25	Proposed Sale	45.59	229	10,440		Jan 03 03:26 PM
CHESS ROBERT	Director	Dec 05 '24	Option Exercise	8.82	3,504	30,905	25,145	Dec 30 04:55 PM
CHESS ROBERT	Director	Dec 05 '24	Sale	51.85	3,504	181,696	21,641	Dec 30 04:55 PM
Cho Dennis	See Remarks	Dec 20 '24	Sale	44.90	316	14,189	113,171	Dec 26 04:05 PM
Green Paula	SVP of Human Resources	Dec 20 '24	Sale	44.90	282	12,663	133,433	Dec 26 04:05 PM
Leproust Emily M.	Chief Executive Officer	Dec 20 '24	Sale	44.90	1,654	74,270	673,064	Dec 26 04:05 PM
Green Paula	Officer	Dec 20 '24	Proposed Sale	44.90	282	12,663		Dec 20 03:39 PM
Cho Dennis	Officer	Dec 20 '24	Proposed Sale	44.90	316	14,189		Dec 20 03:16 PM
Leproust Emily M.	Officer	Dec 20 '24	Proposed Sale	44.90	1,654	74,270		Dec 20 03:16 PM
Cho Dennis	See Remarks	Dec 16 '24	Sale	46.81	133	6,225	113,487	Dec 18 04:05 PM
Cho Dennis	Officer	Dec 16 '24	Proposed Sale	46.81	133	6,225		Dec 16 03:35 PM
Cho Dennis	See Remarks	Dec 06 '24	Sale	52.70	367	19,342	113,620	Dec 10 04:05 PM
Green Paula	SVP of Human Resources	Dec 06 '24	Sale	52.70	860	45,325	133,715	Dec 10 04:05 PM
Leproust Emily M.	Chief Executive Officer	Dec 06 '24	Sale	52.70	2,216	116,792	674,718	Dec 10 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Dec 06 '24	Sale	52.70	226	11,911	53,043	Dec 10 04:05 PM
Cho Dennis	Officer	Dec 06 '24	Proposed Sale	52.70	367	19,342		Dec 06 03:29 PM
Green Paula	Officer	Dec 06 '24	Proposed Sale	52.70	860	45,326		Dec 06 03:26 PM
Leproust Emily M.	Officer	Dec 06 '24	Proposed Sale	52.70	2,216	116,793		Dec 06 03:25 PM
WERNER ROBERT F.	Officer	Dec 06 '24	Proposed Sale	52.70	226	11,911		Dec 06 03:20 PM
CHESS ROBERT	Director	Dec 05 '24	Proposed Sale	51.85	3,504	181,696		Dec 05 03:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TWST

Twist Bioscience Corp

Upgrade your FINVIZ experience